TearLab Corp. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
14,645.00
19,718.00
25,156.00
28,014.00
27,119.00
24,999
Cost of Goods Sold (COGS) incl. D&A
9,361.00
11,558.00
14,058.00
13,384.00
12,980.00
9,304
Gross Income
5,284.00
8,160.00
11,098.00
14,630.00
14,139.00
15,695
SG&A Expense
22,868.00
33,164.00
41,235.00
30,606.00
25,525.00
12,831
EBIT
17,584.00
25,004.00
30,137.00
15,976.00
11,386.00
2,864
Unusual Expense
11,295.00
1,175.00
1,145.00
26.00
446.00
402
Non Operating Income/Expense
146.00
79.00
76.00
31.00
44.00
4
Interest Expense
-
-
2,023.00
3,949.00
4,225.00
4,709
Pretax Income
28,990.00
23,722.00
33,229.00
19,920.00
16,101.00
2,251
Consolidated Net Income
28,990.00
23,722.00
33,229.00
19,920.00
16,101.00
2,251
Net Income
28,990.00
23,722.00
33,229.00
19,920.00
16,101.00
2,251
Net Income After Extraordinaries
28,990.00
23,722.00
33,229.00
19,920.00
16,101.00
2,251
Net Income Available to Common
28,990.00
23,722.00
33,229.00
19,920.00
16,101.00
2,251
EPS (Basic)
9.40
7.10
9.90
4.29
2.78
0.21
Basic Shares Outstanding
3,075.90
3,357.90
3,369.80
4,648.00
5,789.70
10,615.50
EPS (Diluted)
9.42
7.04
9.85
4.29
2.78
0.21
Diluted Shares Outstanding
3,075.90
3,371.70
3,373.20
4,648.00
5,789.70
10,615.50
EBITDA
15,717.00
22,066.00
26,522.00
12,473.00
9,399.00
4,075
Non-Operating Interest Income
35.00
28.00
-
-
-
-
About TearLab
View Profile
